Amarin Corp Plc (AMRN)

[cmm3rd]

"This is the first demonstration that when you actually alter [TRL cholesterol] with drug therapy and you reduce it by one standard deviation independent of LDL change, there is an independent association with clinical events," Ray said. "This would suggest that future therapies that modify that fraction will independently lower risk."

If FDA is wants an excuse/cover to get out of this trap by reinstating the SPA and granting the sNDA, they just got it. I will be sending the article to Dr. Woodcock.

Thanks for posting.